Clik here to view.
Motion-directed microrobots for targeted drug delivery
Researchers have created tiny ‘microbots’ that are able to move and react in a fashion similar to bacteria, according to a report from the Max Planck Institute for Intelligent Systems. Bacteria use...
View ArticleClik here to view.
HHS: Medicare spent $1.5B on faulty cardiac devices
Medicare spent approximately $1.5 billion on defective heart devices implanted in thousands of beneficiaries, according to a report from the Department of Health and Human Services released in late...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 5, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Amedica reduces workforce by 38%
Amedica (NSDQ:AMDA) said today it laid off approximately 38% of its workforce to lower operating expenses. The Salt Lake City, Utah-based company said the layoffs were part of a plan implemented on...
View ArticleClik here to view.
Report: Drug device market to reach $1.8B by 2024
The global drug device combination market is expected to reach $17.7 billion by 2024, according to a new report from Grand View Research. The report points to minimally invasive alternatives like...
View ArticleClik here to view.
AngioSoma taps La Jolla Capital for Liprostin JV
AngioSoma (OTCQB:SOAN) said today that it landed a joint venture with La Jolla Capital to help fund and manage phase III trials studying its flagship product, Liprostin. The Montgomery, Texas-based...
View ArticleClik here to view.
‘Connectosomes’ efficiently deliver chemo to targeted cells
Researchers have developed a new form of nanoparticles called “connectosomes” that can efficiently deliver chemotherapy to human cells more efficiently than traditional delivery methods, according to a...
View ArticleClik here to view.
Report: Voice box prostheses may only last three months
(Reuters) – Tracheoesophageal voice prosthetic devices often last less than 3 months before they need to be replaced, which is a shorter lifespan than previously reported, according to a new study. “In...
View ArticleClik here to view.
Organovo unveils bioprinted liver transplant patches
Organovo (PINK:ONVO) today announced it is developing 3D bioprinted human liver tissue designed for direct transplantation to patients. The move to human development comes based on “strong results”...
View ArticleClik here to view.
Colombia allows faster renewals for lower-risk medical devices
By Stewart Eisenhart, Emergo Group EMERGO SUMMARY OF KEY POINTS: Colombian regulator INVIMA is speeding up registration renewals for Class I and IIa medical devices. Registrants must still submit...
View ArticleClik here to view.
ICU Medical to pay Pfizer $1B for Hospira infusion pump biz
ICU Medical (NSDQ:ICUI) agreed to pay $1 billion in cash and stock for the Hospira infusion pump business owned by Pfizer (NYSE:PFE), confirming rumors that swirled earlier this year that the drug...
View ArticleClik here to view.
FDA approves St. Jude Medical’s Infinity DBS and directional leads
St. Jude Medical (NYSE:STJ) said today that the FDA approved its Infinity deep-brain stimulation device, including its DBS directional leads, to treat Parkinson’s disease and essential tremor. The...
View ArticleClik here to view.
BTG’s U.S. Biocompatibles business to pay $36m to settle Justice Dept. beef
BTG (LON:BTG) said today that it agreed to pay the U.S. Justice Dept. $36 million (£28.4 million) to settle a probe into the marketing of the LC Bead embolization microspheres made by its...
View ArticleClik here to view.
AngioDynamics shares droop despite swing to Q1 black
AngioDynamics (NSDQ:ANGO) reported its 1st quarter results for fiscal 2017 yesterday, posting a 5% top-line gain and a swing to black ink. Despite the good news, ANGO shares closed down more than 6%...
View ArticleClik here to view.
Obalon Therapeutics prices $75m IPO
Obalon Therapeutics yesterday priced its initial public offering at $75 million, in line with the range it set last month. The weight loss device maker said it plans to float 5 million shares at $15...
View ArticleClik here to view.
THINK SMALL: RAUMEDIC at Compamed
As a polymer component system provider for the medical technology and pharmaceutical industry, RAUMEDIC will be appearing at the leading international marketplace for the medical supply industry. The...
View ArticleClik here to view.
Ra Medical wins dual CE Marks for atherectomy catheter, dermal excimer laser
Medical excimer laser developer Ra Medical said today it won CE Mark approval in the European Union for both its Dabra artherectomy catheter system and its Pharos excimer laser designed to treat skin...
View ArticleClik here to view.
Baxter recalls select IV fluid filters
Baxter (NYSE:BAX) is recalling its 50mm 0.2 micron filter used to filter water-based intravenous solutions due to the presence of particulate mater and the potential absence of filter layers. The FDA...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 6, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Brigham doc wins $75m heart disease research grant
Boston-based Brigham and Women’s Hospital cardiovascular medicine chief Dr. Calum MacRae won a $75 million heart disease research grant from the American Heart Association to investigate coronary heart...
View Article